-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
The antibody against B3GALNT2 was raised in rabbit using the Human B3GALNT2 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.
The antibody against B3GALNT2 was raised in rabbit using the Human B3GALNT2 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.
$600.00
| Cat.No | ADC-54018A | Clonality | Polyclonal |
|---|---|---|---|
| Host Species | Rabbit | Target Name | B3GALNT2 |
| Target Synonyms | 3 galactosaminyltransferase 2 antibody; Beta 1, 3 galactosaminyltransferase polypeptide 2 antibody; UDP-GalNAc:beta-1 antibody; UDP-GalNAc:beta-1, 3 N acetylgalactosaminyltransferase 2 antibody; Beta 1, 3 N acetylgalactosaminyltransferase II antibody; Beta 1, 3 N acetylgalactosaminyltransferase II MGC39558 antibody; Beta 3 GalNAc T2 antibody; Beta-1 antibody; beta-1, 3-GalNAc-T2 antibody; Beta3GalNAcT2 antibody; MDDGA11 antibody; MGC39558 antibody; UDP GalNAc:betaGlcNAc beta 1, 3-N-acetylgalactosaminyltransferase 2 antibody | Form | Liquid |
| Species Reactivity | Human, Mouse, Rat | Isotype | IgG |
| Storage Buffer | 50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.02% sodium azide | Purification Method | Antigen affinity purified |
| Conjugate | Non-conjugated | Application | ELISA, WB |
| Storage | Upon receipt |
| Immunogen Description | Human B3GALNT2 | Target Species | Human |
|---|---|---|---|
| Immunogen Sequence | Complete sequences for the immunogen, target protein, and peptides are available upon request. | Uniprot ID | Q8NCR0 |
Uniprot Id
Q8NCR0
Target Species
Human
Target Name
B3GALNT2
Target Full Name
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2
Target Function
Beta-1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. Has no galactose nor galactosaminyl transferase activity toward any acceptor substrate. Involved in alpha-dystroglycan (DAG1) glycosylation: acts coordinately with GTDC2/POMGnT2 to synthesize a GalNAc-beta3-GlcNAc-beta-terminus at the 4-position of protein O-mannose in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan, which is required for binding laminin G-like domain-containing extracellular proteins with high affinity.
Target Involvement
Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 (MDDGA11)
Target Subcellular Location
Golgi apparatus membrane; Single-pass type II membrane protein. Endoplasmic reticulum.
Target Protein Families
Glycosyltransferase 31 family
Target Tissue Specificity
Expressed in all tissues examined, but at highest levels in testis, adipose tissue, skeletal muscle and ovary.
Target Synonyms
3-GalNAc-T2; 3-N-acetylgalactosaminyltransferase 2; 3-N-acetylgalactosaminyltransferase II; B3GalNAc T2; B3GalNAcT2; b3galnt2; B3GL2_HUMAN; Beta 1,3 galactosaminyltransferase 2; Beta 1,3 N acetylgalactosaminyltransferase 2; Beta 1,3 N acetylgalactosaminyltransferase II; Beta 1,3 N acetylgalactosaminyltransferase II MGC39558; Beta 3 GalNAc T2; Beta-1; beta-1,3-GalNAc-T2; Beta3GalNAcT2; MDDGA11; MGC39558; UDP GalNAc:betaGlcNAc beta 1,3 galactosaminyltransferase polypeptide 2; UDP-GalNAc:beta-1; UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2
Notification